Designing biologics, delivering patient care.
Biopartners is dedicated to improving quality of life through significant advancements in patient care. We are a dynamic and growing biopharmaceutical company, leading the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, oncology and virology. Our comprehensive product portfolio consists of first-generation biopharmaceuticals with innovative-formulations or novel delivery systems.
A Pioneer in Biopharmaceuticals
We are on track to be the first company to submit a sustained-release formulation of recombinant human growth hormone which will cut the number of self-administered injections from once-a-day to once-a-week - a major breakthrough in hGH treatment.